GENE | HGNC_ID | MARKER_TYPE | CANCER_TYPE | HISTOLOGICAL_TYPE | CELL_LINE | CSC_ENRICHMENT | METHOD | EXPRESSION_LEVEL | CONFIDENCE_SCORING | GLOBAL_SCORING | PUBMED_ID |
---|
CD44 | 1681 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | HN4 | NA | SFA followed by Western Blotting and IF staining | NA | 0.52 | 1 | 25749385
|
CD44 | 1681 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | HN4 | Cisplatin | Western Blotting and FACs followed by SFA | NA | 0.52 | 1 | 34795388
|
CD44 | 1681 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | HN4 | NA | SFA and Western Blotting | NA | 0.52 | 1 | 32194902
|
ALDH1A1 | 402 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | HN4 | Cisplatin | Western Blotting followed by SFA | NA | 0.28 | 0.684 | 34795388
|
BMI1 | 1066 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | HN4 | Cisplatin | Western Blotting followed by SFA | NA | 0.28 | 0.1135 | 34795388
|
BMI1 | 1066 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | HN4 | NA | SFA and Western Blotting | NA | 0.28 | 0.1135 | 32194902
|
NANOG | 20857 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | HN4 | Cisplatin | Western Blotting followed by SFA | NA | 0.28 | 0.5461 | 34795388
|
POU5F1 | 9221 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | HN4 | Cisplatin | Western Blotting followed by SFA | NA | 0.28 | 0.6448 | 34795388
|
POU5F1 | 9221 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | HN4 | NA | SFA and Western Blotting | NA | 0.28 | 0.6448 | 32194902
|
SOX2 | 11195 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | HN4 | Cisplatin | Western Blotting followed by SFA | NA | 0.28 | 0.5695 | 34795388
|